Trial intelligence / Profile preview

Phase II PAD induction therapy in previously untreated multiple myeloma with deferred ASCT

ISRCTN03381785Phase 2Completed

Sponsor

University College London

Start

Nov 2010

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules